Suppr超能文献

来自增生性和恶性前列腺组织的纤溶酶原激活剂的分离与鉴定

Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.

作者信息

Kirchheimer J, Köller A, Binder B R

出版信息

Biochim Biophys Acta. 1984 Feb 14;797(2):256-65. doi: 10.1016/0304-4165(84)90129-6.

Abstract

Plasminogen activators from prostate tissue were purified to apparent homogeneity by a procedure involving reverse ammonium sulfate gradient solubilization, chromatography on gelatine-Sepharose, gel filtration on Sephadex G-150, and chromatography on Con A-Sepharose as a final step. Two activators were obtained. The predominant one exhibited physicochemical, immunochemical and functional properties indistinguishable from human urinary high molecular weight urokinase. The other one, which amounted to about 20% was immunochemically related to tissue type plasminogen activator and its plasminogen activator activity was enhanced by addition of CNBr-fibrinogen fragments in a similar pattern as for the vascular plasminogen activator. The molecular weight, however, and enzymatic activities on the synthetic low molecular weight paranitroanilide substrates pyro-Glu-Gly-Arg-pNA and H-D-Ile-Pro-Arg-pNA were different to vascular plasminogen activator but similar to high molecular weight urinary urokinase.

摘要

通过一系列步骤从前列腺组织中纯化纤溶酶原激活剂至表观均一性,这些步骤包括硫酸铵梯度反向溶解、明胶-琼脂糖凝胶色谱、葡聚糖凝胶G-150凝胶过滤以及以伴刀豆球蛋白A-琼脂糖凝胶色谱作为最后一步。获得了两种激活剂。主要的一种在物理化学、免疫化学和功能特性方面与人尿高分子量尿激酶无法区分。另一种约占20%,在免疫化学上与组织型纤溶酶原激活剂相关,并且其纤溶酶原激活剂活性通过添加氰基溴化纤维蛋白原片段而增强,其模式与血管纤溶酶原激活剂相似。然而,其分子量以及对合成的低分子量对硝基苯胺底物焦谷氨酸-甘氨酸-精氨酸-对硝基苯胺和H-D-异亮氨酸-脯氨酸-精氨酸-对硝基苯胺的酶活性与血管纤溶酶原激活剂不同,但与高分子量尿激酶相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验